Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Anticoagulation of patients with heparin-induced thrombocytopenia (HIT) may be limited by cross-reaction of HIT antibodies with danaparoid and generation of antibodies during therapy with lepirudin. We used fondaparinux to treat 6 patients with a history of HIT with thromboembolism and 2 patients with thrombocytopenia during low-molecular-weight heparin administration.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on